CAS 117570-53-3 – 5,6-Dimethylxanthenone-4-Acetic… | In Stock

CAS No.

117570-53-3

MDL No.

MFCD00870555

C₁₇H₁₄O₄

282.29

InChI Key

XGOYIMQSIKSOBS-UHFFFAOYSA-N

Pack Size	Purity	Price	Availability
100 mg	98%	$35	In Stock
250 mg	98%	$62	In Stock
1 g	98%	$189	In Stock
5 g	98%	$907	In Stock
10 g	98%	$1608	In Stock
Custom synthesis and bulk supply options are available upon request.

Pack Size

Purity

Price

Availability

Action

100 mg

98%

$35

In Stock

250 mg

98%

$62

In Stock

1 g

98%

$189

In Stock

5 g

98%

$907

In Stock

10 g

98%

$1608

In Stock

Custom synthesis and bulk supply options are available upon request.

Product Information

Vadimezan is a monocarboxylic acid derived from acetic acid, with one methyl hydrogen replaced by a 5,6-dimethyl-9-oxoxanthen-4-yl group. It functions as an antineoplastic agent and belongs to the class of xanthones.

CAS No.	117570-53-3
Product Name	5,6-Dimethylxanthenone-4-Acetic Acid

Associated Conditions

neoplasm·lung cancer·prostate cancer·urothelial carcinoma·non-small cell lung carcinoma

* The information provided here is compiled from public sources and is for reference only.

5,6-Dimethylxanthenone-4-Acetic Acid

Pricing & Availability

Product Information

Biological Profile

Safety Information

Properties

Associated Conditions

Documentation

5,6-Dimethylxanthenone-4-Acetic Acid

Pricing & Availability

Product Information

Biological Profile

Safety Information

Properties

Associated Conditions

Related Articles

Comparative effects of combretastatin A-4 disodium phosphate and 5,6-dimethylxanthenone-4-acetic acid on blood perfusion in a murine tumour and normal tissues.

Interferon-inducible protein 10 induction and inhibition of angiogenesis in vivo by the antitumor agent 5,6-dimethylxanthenone-4-acetic acid (DMXAA).

Vascular attack by 5,6-dimethylxanthenone-4-acetic acid combined with B7.1 (CD80)-mediated immunotherapy overcomes immune resistance and leads to the eradication of large tumors and multiple tumor foci.

Reversible binding of the novel anti-tumour agent 5,6-dimethylxanthenone-4-acetic acid to plasma proteins and its distribution into blood cells in various species.

Documentation